HepaRegeniX
GermanyEntry
2016
Hold
10yr
Status
Active
Who owns HepaRegeniX?
HepaRegeniX is currently owned by High-Tech Gruenderfonds (HTGF) through HTGF II (2011 vintage), since 2016. Across its history, HepaRegeniX has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-03
Most recent investor
High-Tech Gruenderfonds (HTGF)HTGF II · 2011 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-held by Novo Holdings, Boehringer Ingelheim Venture Fund and High-Tech Gruenderfonds (HTGF) since 2016.
Co-invest · 3 holders · 2016 · present
Novo HoldingsActive
2016 · present(10yr) · Novo Holdings Venture Investments · 1999 · VC
More from HTGF II
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack HepaRegenix
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy HepaRegenix?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on HepaRegenix.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue